Demelon Capsule 1.5 mg contains Rivastigmine Tartrate 1.5 mg, a cholinesterase inhibitor used to manage mild to moderate dementia associated with Alzheimer’s disease and Parkinson’s disease. Rivastigmine works by inhibiting acetylcholinesterase and butyrylcholinesterase, enzymes responsible for breaking down acetylcholine, a neurotransmitter essential for memory, learning, and cognition. By increasing acetylcholine levels in the brain, Demelon helps improve cognitive function, attention, and daily living abilities in patients with dementia.

Dementia is a progressive neurological disorder that impairs memory, reasoning, and functional independence. Symptoms may include forgetfulness, confusion, difficulty performing daily tasks, and changes in behavior or mood. Demelon Capsule 1.5 mg provides an initial low-dose therapy that allows patients to begin treatment safely, minimizing potential side effects while enabling gradual dose titration to achieve optimal therapeutic effect. Its oral capsule formulation ensures precise dosing and convenient administration for both adult and elderly patients.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Indications

Demelon Capsule 1.5 mg is indicated for:

• Treatment of mild to moderate Alzheimer’s disease

• Management of Parkinson’s disease dementia

• Improvement of memory, attention, and cognitive function in dementia patients

• Support of daily living activities and overall quality of life in patients with early-stage dementia

Key Benefits

• Enhances cholinergic neurotransmission, improving memory and cognition

• Slows the progression of symptoms in early to moderate dementia

• Improves attention, reasoning, and the ability to perform daily tasks

• Low starting dose reduces the risk of gastrointestinal and other side effects

• Oral capsule form allows easy, accurate, and flexible dosing

Mechanism of Action

Rivastigmine Tartrate is a reversible inhibitor of acetylcholinesterase and butyrylcholinesterase, which are enzymes that degrade acetylcholine in the brain. By preventing acetylcholine breakdown, rivastigmine increases its concentration at synapses, improving communication between neurons. This enhanced cholinergic signaling helps restore cognitive abilities, memory retention, and learning capacity, which are often impaired in patients with dementia.

Dosage and Administration

• Starting dose: 1.5 mg twice daily, taken orally.

• Capsules should be swallowed whole with water and preferably with meals to reduce gastrointestinal discomfort.

• Dose may be gradually increased based on patient tolerance and physician guidance, usually in 1.5 mg increments up to the target therapeutic dose.

• Consistent daily dosing is essential for maintaining effective drug levels and achieving cognitive improvement.

Precautions

• Use cautiously in patients with heart conditions, gastric ulcers, liver or kidney impairment, or a history of seizures.

• Monitor for gastrointestinal symptoms, weight changes, or slow heart rate (bradycardia).

• Avoid abrupt discontinuation; always consult a healthcare provider before stopping or adjusting the dose.

• Inform the physician about all other medications to prevent drug interactions.

• Not recommended for patients with severe dementia or known hypersensitivity to rivastigmine.

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Possible Side Effects

Demelon Capsule 1.5 mg is generally well tolerated. Possible side effects include:

• Nausea and vomiting

• Loss of appetite

• Diarrhea

• Dizziness or headache

• Rarely, bradycardia or fainting

Most side effects are mild, transient, and often resolve with continued therapy or gradual dose titration.

Storage

Store below 30°C in a cool, dry place, protected from light and moisture. Keep out of reach of children.